Rheumatoid arthritis isn’t currently curable. But treatments can help manage symptoms, improve quality of life, support movement, and slow disease progression. Speak to a doctor about which ...

Clinical and Radiographic Outcomes of Four Different Treatment Strategies in Patients With Early Rheumatoid Arthritis (the Best Study): A Randomized, Controlled Trialfrom Arthritis & Rheumatism.

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...

Rheumatoid arthritis (RA) is a type of autoimmune disease in which your body attacks healthy joint tissue. Common symptoms of RA include morning stiffness and joint pain, typically in the same ...

This article explores the complex roles of cytokine networks in the development and progression of autoimmune diseases.

Rheumatoid arthritis (RA) is a prototype immune-mediated inflammatory disease, characterised by a symmetric polyarthritis usually involving the small joints of the hands and feet. Other joints can ...

There are many types of arthritis. The two most common types are osteoarthritis (OA), caused by repetitive movements, and rheumatoid arthritis (RA), an autoimmune disease. There is no cure for ...

You can manage joint pain with exercise, a healthy diet, physical therapy, and supportive tools. See a doctor if joint pain ...

As a practicing rheumatologist, he cares for adults with systemic autoimmune diseases (such as lupus, rheumatoid arthritis, vasculitis, and myositis) and various kinds of arthritis. After ...

This marks a major milestone in the development of IHL-42X, confirming the completion of clinical data collection and enabling final statistical analysis to begin. The Company is on track to deliver ...

Your doctor might also ask for blood tests to rule out other conditions as the cause of pain, such as rheumatoid arthritis. Finally, if needed, your doctor might want to take some fluid from your ...

Phase 2 results were positive for ILYX-002, a topical immunomodulator for moderate to severe dry eye disease associated with systemic autoimmune or inflammatory conditions, according to a press ...